Haugen Janet Brutschea sold 2,114 shares
- Sold 2,114.18 shares of WST
- Date of transaction: 09/30/2026
- Phantom stock units settled on termination as director
Janet Brutschea Haugen
Every EDGAR filing for WEST PHARMACEUTICAL SERVICES INC (WST), newest first, with AI summaries and stories.
Next: earnings expected ~Oct 26 · 10-Q expected ~Oct 26 (deadline Nov 9)
No open-market insider buys in the last 30 days.
Janet Brutschea Haugen
Annette F Favorite, insider filing for WST
Annette F Favorite, reporting
Annette F Favorite, insider filing for WST
Annette F Favorite, reporting
Michel Lagarde, insider filing for WST
Michel Lagarde, reporting
Robert W. McMahon, insider filing for WST
Robert W. McMahon, reporting
Ownership stake disclosure by FMR LLC
FMR LLC, filed by
Janet Brutschea Haugen, insider filing for WST
Janet Brutschea Haugen, reporting
Shane Alden Campbell, insider filing for WST
Shane Alden Campbell, reporting
Thomas W Hofmann, planned sale of WST shares
Thomas W Hofmann, reporting
Paolo Pucci, insider filing for WST
Paolo Pucci, reporting
Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC, filed by
Annette F Favorite, insider filing for WST
Annette F Favorite, reporting
Janet Brutschea Haugen, insider filing for WST
Janet Brutschea Haugen, reporting
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Chad Winters, insider filing for WST
Chad Winters, reporting
Rodolphe Jean Poussot, insider filing for WST
Rodolphe Jean Poussot, reporting
Rodolphe Jean Poussot, insider filing for WST
Rodolphe Jean Poussot, reporting